✦ LIBER ✦

Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: A non-randomized phase II study

✍ Scribed by Surmont, V.; Aerts, J.G.; Pouw, E.; Tan, K.Y.; Vernhout, R.; Gras, J.; Salomé, J.; Pronk, T.; Schmitz, P.I.M.; Hoogsteden, H.; van Klaveren, R.J.

Book ID: 119320133
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 198 KB
Volume: 66
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2009.02.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of oral UFT and cisplatin

Phase II trial of oral UFT and cisplatin in non-small cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Oral etoposide preceding cisplatin in ad

Oral etoposide preceding cisplatin in advanced non small cell lung cancer (NSCLC). A phase II study

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB

Prolonged administration of oral etoposi

Prolonged administration of oral etoposide in non-small-cell lung cancer: A phase II trial

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 166 KB

The role of UFT and the combination of U

The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer

✍ Langer, Corey J 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB

A phase II study of vindesine plus etopo

A phase II study of vindesine plus etoposide in metastatic non-small cell lung cancer

✍ Hupperets, P.S.G.J.; ten Velde, G.P.M.; Bron, H.; Schouten, L.; Blijham, G.H. 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 305 KB

A phase II study of gemcitabine plus ora

A phase II study of gemcitabine plus oral etoposide (GOE) in treatment of advanced non-small cell lung cancer

✍ T.S.K. Mok; A.T.C. Chan; T.W.T. Leung; S.F. Leung; A. Yim; W. Yeo; W.T. Yang; H. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 163 KB